OPKO Health Total Assets 2010-2024 | OPK

OPKO Health total assets from 2010 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.
OPKO Health Annual Total Assets
(Millions of US $)
2023 $2,012
2022 $2,167
2021 $2,400
2020 $2,473
2019 $2,309
2018 $2,451
2017 $2,590
2016 $2,767
2015 $2,799
2014 $1,268
2013 $1,392
2012 $290
2011 $229
2010 $78
2009 $87
OPKO Health Quarterly Total Assets
(Millions of US $)
2024-09-30 $2,256
2024-06-30 $1,980
2024-03-31 $1,974
2023-12-31 $2,012
2023-09-30 $2,057
2023-06-30 $2,159
2023-03-31 $2,170
2022-12-31 $2,167
2022-09-30 $2,225
2022-06-30 $2,370
2022-03-31 $2,307
2021-12-31 $2,400
2021-09-30 $2,418
2021-06-30 $2,422
2021-03-31 $2,520
2020-12-31 $2,473
2020-09-30 $2,371
2020-06-30 $2,324
2020-03-31 $2,233
2019-12-31 $2,309
2019-09-30 $2,370
2019-06-30 $2,456
2019-03-31 $2,575
2018-12-31 $2,451
2018-09-30 $2,481
2018-06-30 $2,531
2018-03-31 $2,579
2017-12-31 $2,590
2017-09-30 $2,722
2017-06-30 $2,769
2017-03-31 $2,760
2016-12-31 $2,767
2016-09-30 $2,800
2016-06-30 $2,774
2016-03-31 $2,793
2015-12-31 $2,799
2015-09-30 $3,016
2015-06-30 $1,525
2015-03-31 $1,512
2014-12-31 $1,268
2014-09-30 $1,295
2014-06-30 $1,327
2014-03-31 $1,356
2013-12-31 $1,392
2013-09-30 $1,383
2013-06-30 $641
2013-03-31 $654
2012-12-31 $290
2012-09-30 $250
2012-06-30 $230
2012-03-31 $232
2011-12-31 $229
2011-09-30 $151
2011-06-30 $160
2011-03-31 $176
2010-12-31 $78
2010-09-30 $68
2010-06-30 $68
2010-03-31 $87
2009-12-31 $87
2009-09-30 $84
2009-06-30 $60
2009-03-31 $19
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $1.024B $0.864B
OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $217.348B 26.52
Intuitive Surgical (ISRG) United States $203.988B 93.58
Alcon (ALC) Switzerland $45.073B 30.16
Edwards Lifesciences (EW) United States $41.952B 26.64
IQVIA Holdings (IQV) United States $35.950B 19.81
IDEXX Laboratories (IDXX) United States $34.289B 40.38
DexCom (DXCM) United States $33.759B 50.84
Waters (WAT) United States $23.998B 35.49
STERIS (STE) Ireland $21.743B 25.03
SONOVA HOLDING (SONVY) Switzerland $20.798B 0.00
Hologic (HOLX) United States $16.119B 17.50
Fresenius Medical Care AG KGaA (FMS) Germany $14.577B 14.96
Globus Medical (GMED) United States $12.635B 32.00
Sysmex ADR (SSMXY) Japan $12.243B 38.39
Penumbra (PEN) United States $10.352B 101.40
Masimo (MASI) United States $9.509B 46.01
Glaukos (GKOS) United States $8.767B 0.00
Teleflex (TFX) United States $8.387B 13.38
Integer Holdings (ITGR) United States $4.804B 27.23
Inari Medical (NARI) United States $4.666B 0.00
PROCEPT BioRobotics (PRCT) United States $3.807B 0.00
Veracyte (VCYT) United States $3.444B 103.35
LivaNova (LIVN) United Kingdom $2.755B 15.90
Nihon Kohden (NHNKY) Japan $2.554B 19.40
Tandem Diabetes Care (TNDM) United States $2.388B 0.00
Elekta AB (EKTAY) Sweden $2.309B 20.76
TransMedics (TMDX) United States $2.199B 69.71
Integra LifeSciences Holdings (IART) United States $2.016B 10.53
Alphatec Holdings (ATEC) United States $1.710B 0.00
Artivion (AORT) United States $1.309B 86.72
RxSight (RXST) United States $1.273B 0.00
Pulse Biosciences (PLSE) United States $1.214B 0.00
Paragon 28 (FNA) United States $1.088B 0.00
AxoGen (AXGN) United States $0.806B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.795B 13.51
IRadimed (IRMD) United States $0.759B 40.99
Mesa Laboratories (MLAB) United States $0.743B 17.51
SiBone (SIBN) United States $0.722B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.715B 0.00
Treace Medical Concepts (TMCI) United States $0.649B 0.00
OrthoPediatrics (KIDS) United States $0.602B 0.00
AngioDynamics (ANGO) United States $0.504B 0.00
Delcath Systems (DCTH) United States $0.500B 0.00
ClearPoint Neuro (CLPT) United States $0.491B 0.00
Semler Scientific (SMLR) United States $0.483B 25.41
NeuroPace (NPCE) United States $0.438B 0.00
Tactile Systems Technology (TCMD) United States $0.429B 23.23
Pacific Biosciences Of California (PACB) United States $0.427B 0.00
CVRx (CVRX) United States $0.409B 0.00
Inogen (INGN) United States $0.298B 0.00
Alpha Tau Medical (DRTS) Israel $0.255B 0.00
Accuray (ARAY) United States $0.223B 0.00
Anteris Technologies Global (AVR) Australia $0.214B 0.00
KORU Medical Systems (KRMD) United States $0.197B 0.00
Nevro (NVRO) United States $0.190B 0.00
Sight Sciences (SGHT) United States $0.155B 0.00
LENSAR (LNSR) United States $0.129B 0.00
Sensus Healthcare (SRTS) United States $0.110B 11.75
Atossa Genetics (ATOS) United States $0.107B 0.00
Spectral Diagnostics (EDTXF) Canada $0.105B 0.00
Neuronetics (STIM) United States $0.097B 0.00
Monogram Orthopaedics (MGRM) United States $0.096B 0.00
EDAP TMS S.A (EDAP) France $0.085B 0.00
908 Devices (MASS) United States $0.082B 0.00
Vicarious Surgical (RBOT) United States $0.076B 0.00
Hyperfine (HYPR) United States $0.072B 0.00
Rapid Micro Biosystems (RPID) United States $0.069B 0.00
InspireMD (NSPR) Israel $0.063B 0.00
Covalon Technologies (CVALF) Canada $0.059B 30.86
EnVVeno Medical (NVNO) United States $0.055B 0.00
Lucid Diagnostics (LUCD) United States $0.053B 0.00
Positron (POSC) United States $0.051B 0.00
Baird Medical Investment Holdings (BDMD) $0.046B 0.00
Microbot Medical (MBOT) United States $0.036B 0.00
WORK Medical Technology Group (WOK) China $0.036B 0.00
Spectral AI (MDAI) United States $0.034B 0.00
Accelerate Diagnostics (AXDX) United States $0.033B 0.00
Precision Optics (POCI) United States $0.032B 0.00
Envoy Medical (COCH) United States $0.032B 0.00
NexGel (NXGL) United States $0.024B 0.00
DarioHealth (DRIO) United States $0.022B 0.00
Biosig Technologies (BSGM) United States $0.016B 0.00
Adagio Medical Holdings (ADGM) United States $0.015B 0.00
Ekso Bionics Holdings (EKSO) United States $0.014B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.012B 0.00
PAVmed (PAVM) United States $0.007B 0.00
Aspira Women's Health (AWH) United States $0.007B 0.00
Check-Cap (CHEK) Israel $0.006B 0.00
Tenon Medical (TNON) United States $0.005B 0.00
Nuwellis (NUWE) United States $0.005B 0.00
T2 Biosystems (TTOO) United States $0.005B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.004B 0.00
Autonomix Medical (AMIX) United States $0.004B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
Venus Concept (VERO) Canada $0.003B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Avinger (AVGR) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.001B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00